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Introduction
The use of biomarkers (defined as indicators of exposure, effect, and individual susceptibility) is relatively recent. Many of the methods used have not been extensively validated and it is not known, in most instances, to what extent the biomarkers predict the risk of mutation or cancer.
In this paper we will review, subjectively, some areas of biomarker research that are familiar to us. The areas covered include DNA adducts, adducts and mutations, and mutations in oncogenes and tumor suppressor genes, including their products, oncoproteins. Mutation epidemiology, whether carried out through a twin or a population registry or linked to a cancer registry, may be a powerful source of new patients for genetic analysis. Because genes involved in familial cancer may also operate in common cancers, a large interest in these genes has developed.
DNA Adducts
In the future, the emphasis in DNA adduct research should be on quantification of specific adducts. For some 10 years, aromatic adduct profiles have been presented in the literature. While serving a purpose as a general adduct level, there is now a need to improve the specificity of adduct studies, aiming at criteria of general analytical chemistry; however, because of multiple steps of analysis, a great deal of standardization is required. The most straightforward approach is to use both external and internal standards for the adducts to be identified. This is not feasible in exposures to complex mixtures such as polycyclic aromatic hydrocarbons (PAHs). The approach is more feasible to adducts, which make only one main type of adduct.
Another kind of general problem with adducts is the use of surrogate tissues instead of target tissues. Furthermore, halflives of adducts are largely unknown even in surrogate tissues. A few studies have addressed these problems.
Smoking is a known risk factor of laryngeal cancer. Aromatic adducts of laryngeal tissue obtained from surgery were analyzed; there was a relationship to smoking, most clearly in the tumor tissue. Both tumor and normal laryngeal tissues showed a correlation of about 0.9 to the total white blood cells (1) .
Smokers had elevated levels of 7-methylguanine, particularly in their lymphocyte DNA as compared to the granulocyte DNA (2) . The adduct levels were highest in the bronchial DNA of smokers, almost four times the level in nonsmokers (3) . In a small number of smokers, both target (bronchial) and surrogate (lymphocyte) DNA were available, showing a correlation of 0.8.
Larynx tissue samples obtained from surgery have also been assayed for 7-methylguanine-DNA adducts. There was a relationship to smoking, and larynx adduct levels were two times the level in white blood cells. There was a modest correlation only between 7-alkylguanines and aromatic adducts.
In the latter part of this section, we will discuss some examples of how the problems of specificity and quantification can be tackled on very different kinds of exposures.
PAH Adducts
We have attempted to study the nature of the aromatic adducts detected in the postlabeled samples from Silesia, an industrialized area of Poland, which has been a focus of our studies for years. The methods applied with samples before postlabeling included nuclease P1 treatment, butanol extraction, and immunoaffinity chromatography (IAC) using an antibody raised against benzo[a]pyrene-modified DNA (4). The results on IAC are shown in Figure 1 . adducts of a number of 3H-labeled PAHs were prepared in a microsomal system and used for optimization and measurements of recoveries in the postlabeling assay. The optimal labeling conditions for all tested compounds were very similar. The recoveries varied from 3 to 60% among different PAHs, indicating that the levels of these adducts could be considerably underestimated when analyzing human samples from PAH-exposed populations (6 The concerns about the harmful effects of engine exhausts have traditionally been focused on polycyclic aromatic compounds (8, 9) . There has been increasing concern about the effects of alkenes such as ethene, propene, butadiene, and isoprene because their epoxides (metabolites in humans) are carcinogenic (10) . The present risk estimates of environmental cancer ascribe cancers approximately equally to butadiene alone as to polycyclic aromatic matter, including PAHs (11) . It is projected that butadiene is increasing overwhelmingly over polycyclic compounds; in 2010, it is estimated that butadiene alone will cause approximately five times more cancer than polycyclic material, based on a comparison of motor vehicle exhausts (11) .
The extraordinary carcinogenicity of butadiene in rodents influences such projections (8) ; however, for this compound human occupational data are also becoming available (12) . New carcinogenic alkenes are still being detected. Isoprene, an analogue of butadiene that possesses two double bonds capable of cross-linking DNA has recently been found to be a potent carcinogen in rodents (10) . It can be assumed that other dialkenes will be found in vehicle exhaust that will alter the risk estimates for particular compounds. Effort should be focused on DNA binding products of alkenes, including butadiene and isoprene. The occupational groups that are most heavily exposed include tank truck drivers, tank ship unloaders, butadiene manufacturing workers, and garage workers. The method of adduct detection can rely on the newly developed postlabeling technique for monoadducts (7) , which has been successfully used in studies of experimental animals exposed to 1-alkenes ( Figure 2 ) (13).
UV-Adducts
For cross-links, the technique used for cisplatinum and UV cross-links can be applied (14, 15) . This modification of the postlabeling technique (Figure 3 ) is necessary because cross-linked dinucleotides label vary poorly (14, 15 Figure 4 , analyzed by HPLC radioactivity detection.
UV-Adducts and Mutations
The incidence of malignant melanoma and other skin cancers has increased markedly in many countries with primarily fairskinned populations (16) . In Sweden the incidence of malignant melanoma and nonmelanomatous skin cancer has increased more than any type of cancer, representing 4.5 and 3.2% annual increases during the last 20-year time period, respectively. Solar ultraviolet (UV)-irradiation is thought to be an important cause of the nonmelanomatous skin cancer, but it may also contribute to melanoma (16) . UV light has complex action on biological organisms and is considered a complete carcinogen, with both initiation and promotion capacities in model systems (16, 17) . UV Specific UV-induced photoproducts may be measured by the novel modification of the 32P-postlabeling technique (15) . Further methods development involves adaptation of the method to human skin in situ. UV-induced adducts can be determined in parallel with mutation measurements in the p53 gene. The assay of UV-specific CC to TT mutations in the p53 gene in human skin has been published (19) . CC to TT mutations in the p53 gene are rare in internal organs, which implicates UV as the main causative factor. The codons conveying transforming properties should be complemented with silent mutations that give no growth advantage, thus serving as measures of mutation frequency.
UV-induced photoproducts caused experimentally and through suntanning can be studied in an early biologically effective target dose in human skin of healthy individuals and patients with skin diseases. The in situ transformation of the adducts, including those on the p53 gene, to p53 mutations could be measured in several codons as an early indication of potential hazard for skin cancer in individuals. This would tie different photoproducts to mutations that appear relevant to skin cancers in healthy and predisposed humans. Adducts indicate the target dose at a level of a nucleotide in the p53 gene, DNA repair indicates the efficiency of damage removal, and p53 mutations 20 40 Retention time, min 
Mutation Studies in Tumor Suppressor Genes
Many cancer-related genes are excessively large (20) . This applies to both tumor suppressor genes ( (25) or denaturant gradient gel electrophoresis (DGGE) (26) . In the first application, genomic DNA sequences are amplified, denatured, and analyzed on capillary electrophoresis as single-stranded molecules. In the second application, dubbed constant denaturant capillary electrophoresis (CDCE) (26) , melting profiles of the nucleotide sequences are analyzed; it is important that the sequence to be analyzed contain domains melting both at high and low temperatures. This ensures separation of heteroduplexes containing mismatches identical to DGGE but with a constant denaturant concentration in the capillary. This is different from the SSCP type of analysis in that the samples are analyzed as partially melted heteroduplexes and not as single strands. In both methods, the DNA is available for sequence analysis; however, experience with analysis of certain sequences with capillary electrophoresis will lead to some understanding of the types and locations of the mutations. An extensive sequence analysis is required before the ground rules can be established.
We used the 19 commonly found ras mutants cloned in a plasmid, (Figure 5 ) (27) . We have devised primers that allow us to use SSCP-and DGGE-type capillary electrophoresis and sequences of different lengths in order to compare the separation power of the two methods. Most of the mutations could be detected as homoduplexes and the rest as heteroduplexes ( Figure 5) Registry is one of the largest in the world and the Twin Registry is the largest, these data sources will provide unique patient material for analysis of common cancers using sib pair analysis. However, as the collection of material involves several generations, including a large number of dead persons, logistics have to be worked out for the identification of important genes in common cancers.
Conclusions
This work uses a number of parameters that are currently available to predict the health outcome of the exposures of concern ( Figure 7 proponents of molecular epidemiology, the present-day findings can be translated to risk estimates in the absence of epidemiological data (35) . The relevant exposure data from epidemiological studies date decades back and are usually uncertain (see Figure 7) ; this impedes direct extrapolation to the risks of the current exposure. Furthermore, individual metabolic factors can be taken into consideration.
